TP53 and cancer: Further optimization led to the discovery of RG-7112 (Figure 2 and Figure 3A), which has an MDM2 binding affinity with IC50 = 18 nM and an average cellular activity with IC50 = 400 nM in wt-p53 cancer cells (Table 1).